Skip to main content

Category Health & Wellness

Gene therapy protects against motor neuron disease in rats 

November 12, 2024

The gene therapy approach allowed the non-mutated gene to be expressed in neurons and better support the transportation of proteins, preventing disease.

UW–Madison researchers find persistent problems with AI-assisted genomic studies

November 4, 2024

Researchers are increasingly attempting to work around this problem by bridging data gaps with ever more sophisticated AI tools.

Raw milk is risky, but airborne transmission of H5N1 from cow’s milk is inefficient in mammals.

July 8, 2024

New research suggests that exposure to raw milk infected with the currently circulating virus poses a real risk of infecting humans, but that the virus may not spread very far or quickly to others.

Serendipity reveals new method to fight cancer with T cells

July 2, 2024

Cells treated with “metabolic priming” retained their stem cell-like qualities, thus enhancing their ability to kill cancer cells, transform into durable memory cells, and survive longer in the body.

UW–Madison leading new research collaboration aimed at treating lung scarring diseases

June 27, 2024

An interdisciplinary group of researchers will will investigate the biological processes that promote lung scarring. With the aid of artificial intelligence and advanced 3D modeling, they will also develop and refine new imaging techniques and drug delivery systems that could aid in halting its progression.

Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help.

May 2, 2024

Mice treated with the therapeutic-laden bacteria experienced delayed tumor growth and significantly longer survival compared with mice that received other treatments.

Update from UW–Madison experts on bird flu spread

April 30, 2024

UW experts are assisting efforts to track and research the virus with an eye toward minimizing risk to human health and protecting the state’s agricultural sector.

Three honored for innovation, entrepreneurial excellence

April 18, 2024

Mark Bakken, James Dahlberg, and Dorri McWhorter received the 2024 Chancellor’s Entrepreneurial Achievement Awards. These entrepreneurs exemplify the Wisconsin Idea — UW–Madison’s longstanding commitment to benefiting the world beyond the boundaries of campus.

New tool provides researchers with improved understanding of stem cell aging in the brain

March 27, 2024

By identifying and decoding these autofluorescence signatures, the researchers have developed a tool that can aid in studying adult neurological diseases and aging, but potentially also expand beyond neuroscience.

Air sampling at schools accurately detects flu and COVID-19 virus levels

February 2, 2024

A new study from the Wisconsin School of Medicine and Public Health found that air samplers placed in school cafeterias provided an accurate read of flu and COVID-19 infections in a K-12 school district.

UW–Madison scientists reveal the inner workings of an essential protein trafficking complex

January 3, 2024

The discovery could eventually help researchers better understand and develop new treatments for diseases like cancer, diabetes and those that cause immune dysfunction.

Type 2 diabetes may contribute to racial disparities in colorectal cancer among Americans

November 30, 2023

The findings underscore the value of colonoscopies and other colorectal cancer screenings, especially for Black and lower-income Americans who on average suffer worse outcomes after a cancer diagnosis.

Lauren McLester-Davis becomes UW’s first director of Indigenous science advocacy

November 29, 2023

In this new position, she will weave together science addressing Alzheimer’s disease and dementias, metabolism, and cognitive aging among Indigenous populations in Wisconsin, and other groups often underrepresented in research.

Study: Spike in premature births caused by COVID, halted by vaccines

November 27, 2023

The evidence showing the positive effects of vaccination in preventing premature births could help allay some of the most prominent concerns voiced as COVID-19 vaccines became available to pregnant patients.